University_

Barry and Joy Lambert Cannabinoid Research Scholarships

Postgraduate research scholarships
This scholarship aims to support five PhD students to conduct research into the medicinal potential of cannabis and cannabinoids.

Highlights

Value Eligibility Open date Close date
$30,000 pa (for up to 3.5 years)
  • Future or current PhD student at the University
  • Hold an Honours or master's degree
  • Research the therapeutic potential of cannabis and cannabinoids
5 December 2022 9 February 2023

How to apply

To apply for the scholarship please complete the online application form.

Benefits

This scholarship will provide a stipend allowance of $30,000 per annum for up to three years. An extension for up to six months is available, subject to satisfactory academic performance. 

Who's eligible

You must:

  • have an unconditional offer of admission, or enrolled in your first year of study in a full-time PhD at the University of Sydney
  • conduct research related to the therapeutic potential of cannabis, cannabinoids, cannabinoid based treatments
  • hold an honours or master's degree in science, medical science, medicine, pharmacy or a related discipline
  • be able to demonstrate previous research experience in an area of relevance
  • have at least one supervisor affiliated with the Lambert Initiative for Cannabinoid Therapeutics
  • must also apply for the Research Training Program (RTP) Stipend Scholarship.

An applicant without an unconditional offer of admission may apply and be selected, however, no scholarship offer will be sent until the applicant has an unconditional offer of admission.

Applications to other relevant scholarships are also encouraged.

Background

These scholarships have been donated by Barry and Joy Lambert as part of the philanthropic gift that established the Lambert Initiative.

The purpose of these scholarships are to support PhD students to conduct research into the medicinal potential of cannabis and cannabinoids. The research projects that will be conducted involve the development and evaluation of cannabis based treatments across the following areas.

  • Medicinal and/or analytical chemistry
  • High throughput screening
  • Animal and cellular models of disease
  • Human psychopharmacology
  • Driving research
  • Drug policy
  • Clinical trials

For more information on the scholarships or to discuss the supervision with supervisors visit, Lambert Initiative for Cannabinoid Therapeutics or contact jonathon.arnold@sydney.edu.au, iain.mcgregor@sydney.edu.au or samuel.banister@sydney.edu.au.

1. Background

a. The scholarship is available for an outstanding PhD student to conduct research into medicinal potential of cannabis and cannabinoids at the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics at the Brain and Mind Centre.

b. The Scholarship has been donated by Barry and Joy Lambert as part of the philanthropic gift that established the Lambert Initiative.

c. The intent of the scholarship is to attract high quality applicants to undertake a PhD in cannabinoid science with supervision by Lambert Initiative affiliated scientists.

2. Eligibility

a. This Scholarship is offered subject to the applicant meeting the requirements for an unconditional offer of admission or who is currently enrolled full-time in a PhD at the Lambert Initiative for Cannabinoid Therapeutics at the Brain and Mind Centre, University of Sydney.

b. An applicant who is currently enrolled is only eligible to apply if they have not completed more than one year of full-time study.

c. The applicant must conduct research related to the therapeutic potential of cannabis and cannabinoids.

d. The applicant must have an Honours or Masters degree in science, medical science, medicine, pharmacy, or a related discipline.

e. The applicant must conduct research on cannabinoid based treatments.

f. The applicant must demonstrate previous research experience in an area of relevance.

g. The applicant must have at least one supervisor affiliated with the Lambert Initiative for Cannabinoid Therapeutics.

h. The applicant must have applied for the Research Training Program (RTP) Stipend Scholarship. Applications to other relevant scholarships are also encouraged.

3. Selection Criteria

a. The successful applicant will be awarded the Scholarship on the basis of:

I. academic merit,
II. area of study and research proposal
III. curriculum vitae, and
IV. cover letter which demonstrates interest and any experience in cannabinoid, preclinical or clinical research.

b. The successful applicant will be awarded the Scholarship by the nomination and approval of the Academic Director, Deputy Academic Director and Associate Directors of the Lambert Initiative, or their nominated delegates.

4. Value

a. The Scholarship will provide a stipend allowance of $30,000 per annum for up to 3 years, subject to satisfactory academic performance.

b. The PhD recipient encouraged to complete their PhD in 3 years but may apply for an extension of the primary stipend allowance for up to 6 months.

c. Periods of study already undertaken towards the degree prior to the commencement of the Scholarship will be deducted from the maximum duration of the Scholarship excluding the potential extension period.

d. The Scholarship is for commencement in the relevant research period in which it is offered and cannot be deferred or transferred to another area of research.

e. No other amount is payable.

f. The Scholarship will be offered subject to the availability of funding.

5. Eligibility for Progression

a. Progression is subject to passing the annual progress evaluation meeting.

6. Leave Arrangements

a. The Scholarship recipient receives up to 20 working days recreation leave each year of the Scholarship and this may be accrued. However, the student will forfeit any unused leave remaining when the Scholarship is terminated or complete. Recreation leave does not attract a leave loading and the supervisor's agreement must be obtained before leave is taken.

b. The Scholarship recipient may take up to 10 working days sick leave each year of the Scholarship and this may be accrued over the tenure of the Scholarship. Students with family responsibilities, caring for sick children or relatives, or experiencing domestic violence, may convert up to five days of their annual sick leave entitlement to carer’s leave on presentation of medical certificate(s). Students taking sick leave must inform their supervisor as soon as practicable.

7. Research Overseas

a. The Scholarship recipient may not normally conduct research overseas within the first six months of award.

b. The recipient is required to follow official advice from the University and Department of Foreign Affairs and Travel in light of travel restrictions due to Covid-19.

c. The Scholarship holder may conduct up to 12 months of their research outside Australia. Approval must be sought from the student's supervisor, Head of School and the Faculty via application to the Higher Degree by Research Administration Centre (HDRAC) and will only be granted if the research is essential for completion of the degree.

d. In addition, further approval may be required as outlined in the University of Sydney’s Covid-19 Response Plan.

e. All periods of overseas research are cumulative and will be counted towards a student's candidature. Students must remain enrolled full-time at the University and receive approval to count time away.

f. If the recipient is conducting research outside of Australia, the recipient acknowledges that the University of Sydney is not liable for any costs incurred. This includes but is not limited to: cost of travel and transfers (unless stated under section 4 (Value) of this scholarship to amount listed), delays due to travel restrictions or State and/or Federal quarantine requirements on their return to Australia.

8. Suspension

a. The Scholarship recipient cannot suspend their award within their first six months of study, unless a legislative provision applies.

b. The Scholarship recipient may apply for up to 12 months suspension of the Scholarship for any reason during the tenure of the Scholarship. Periods of Scholarship suspension are cumulative and failure to resume study after suspension will result in the award being terminated. Approval must be sought from the student's supervisor, Head of School and the Faculty via application to the Higher Degree by Research Administration Centre (HDRAC). Periods of study towards the degree during suspension of the Scholarship will be deducted from the maximum tenure of the Scholarship.

9. Changes in Enrolment

a. The Scholarship recipient must notify HDRAC and their supervisor promptly of any planned changes to their enrolment including but not limited to: attendance pattern, suspension, leave of absence, withdrawal, course transfer, and candidature upgrade or downgrade. If the award holder does not provide notice of the changes identified above, the University may require repayment of any overpaid stipend.

10. Termination

a. The Scholarship will be terminated:

I. on resignation or withdrawal of the recipient from their research degree,
II. upon submission of the thesis or at the end of the award,
III. if the recipient ceases to be a full-time student and prior approval has not been obtained to hold the Scholarship on a part-time basis,
IV. upon the recipient having completed the maximum candidature for their degree as per the University of Sydney (Higher Degree by Research) Rule 2011 Policy,
V. if the recipient receives an alternative primary stipend scholarship. In such circumstances this Scholarship will be terminated in favour of the alternative stipend scholarship where it is of higher value,
VI. if the recipient does not resume study at the end of a period of approved leave, or
VII. if the recipient ceases to meet the eligibility requirements specified for this Scholarship, (other than during a period in which the Scholarship has been suspended or during a period of approved leave).

b. The Scholarship may also be terminated by the University before this time if, in the opinion of the University:

I. the course of study is not being carried out with competence and diligence or in accordance with the terms of this offer,
II. the student fails to maintain satisfactory progress, or
III. the student has committed misconduct or other inappropriate conduct.

c. The Scholarship will be suspended throughout the duration of any enquiry/appeal process.

d. Once the Scholarship has been terminated, it will not be reinstated unless due to University error.

11. Misconduct

a. Where during the Scholarship a student engages in misconduct, or other inappropriate conduct (either during the Scholarship or in connection with the student’s application and eligibility for the Scholarship), which in the opinion of the University warrants recovery of funds provided, the University may require the student to repay payments made in connection with the Scholarship. Examples of such conduct include and without limitation; academic dishonesty, research misconduct within the meaning of the Research Code of Conduct (for example, plagiarism in proposing, carrying out or reporting the results of research, or failure to declare or manage a serious conflict of interests), breach of the Code of Conduct for Students and misrepresentation in the application materials or other documentation associated with the Scholarship.

b. The University may require such repayment at any time during or after the Scholarship period. In addition, by accepting this Scholarship, the student consents to all aspects of any investigation into misconduct in connection with this Scholarship being disclosed by the University to the funding body and/or any relevant professional body.

12. Other requirements

a. The scholarship holder must share the outcome and content of their annual progress review with the Operations Committee of the Lambert Initiative for Cannabinoid Therapeutics. This committee is constituted by the Operations Manager, the Academic Director, Deputy Academic Director and Associate Directors of the Lambert Initiative for Cannabinoid Therapeutics, or their nominated delegates.